186 related articles for article (PubMed ID: 23899640)
1. N-acetylcysteine augmentation to tranylcypromine in treatment-resistant major depression.
Carvalho AF; Macêdo DS; Goulia P; Hyphantis TN
J Clin Psychopharmacol; 2013 Oct; 33(5):719-20. PubMed ID: 23899640
[No Abstract] [Full Text] [Related]
2. Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
Goforth HW; Carroll BT
J Clin Psychopharmacol; 2007 Apr; 27(2):216-7. PubMed ID: 17414252
[No Abstract] [Full Text] [Related]
3. Introduction: a fresh look at monoamine oxidase inhibitors for depression.
Cohen LJ; Sclar DA
J Clin Psychiatry; 2012; 73 Suppl 1():3-4. PubMed ID: 22951235
[No Abstract] [Full Text] [Related]
4. Ketamine and Monoamine Oxidase Inhibitor Combination: Utility, Safety, Efficacy?
Bottemanne H; Bonnard E; Claret A; Petit AC; Gaillard R; Fossati P
J Clin Psychopharmacol; 2020; 40(6):636-638. PubMed ID: 33009225
[No Abstract] [Full Text] [Related]
5. Drugs for depression.
Med Lett Drugs Ther; 2016 Jul; 58(1498):85-90. PubMed ID: 27348144
[No Abstract] [Full Text] [Related]
6. [MAO-inhibitors--a treatment option for treatment resistant depression: application, efficacy and characteristics].
Köhler S; Stöver LA; Bschor T
Fortschr Neurol Psychiatr; 2014 Apr; 82(4):228-36; quiz 237-8. PubMed ID: 24710679
[No Abstract] [Full Text] [Related]
7. Tranylcypromine and bupropion combination therapy in treatment-resistant major depression: a report of 2 cases.
Quante A; Zeugmann S
J Clin Psychopharmacol; 2012 Aug; 32(4):572-4. PubMed ID: 22760351
[No Abstract] [Full Text] [Related]
8. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
[TBL] [Abstract][Full Text] [Related]
9. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
10. [Moclobemide].
Gleiter C; Volz HP
Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1175-6. PubMed ID: 7656852
[No Abstract] [Full Text] [Related]
11. Not all monoamine oxidase inhibitors are created equal.
Stewart JT
J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
[No Abstract] [Full Text] [Related]
12. Monoamine oxidase inhibitors revisited: what you should know.
Goldberg JF; Thase ME
J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
[No Abstract] [Full Text] [Related]
13. Tranylcypromine treatment of major depression.
Liebowitz MR
J Clin Psychiatry; 1987 Jul; 48(7):303. PubMed ID: 3597337
[No Abstract] [Full Text] [Related]
14. [Lithium augmentation to monoamine oxidase-inhibitors in treatment-resistant depressive disorders: case report and overview of literature].
Gudde A; van der Meij A; Spijker J
Tijdschr Psychiatr; 2019; 61(7):498-503. PubMed ID: 31372971
[TBL] [Abstract][Full Text] [Related]
15. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
De Gioannis A; De Leo D
Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
[No Abstract] [Full Text] [Related]
16. Commentary on STAR*D: a summary and UK perspective.
Cowen PJ
J Psychopharmacol; 2009 Aug; 23(6):618-9; discussion 622-4. PubMed ID: 19395431
[No Abstract] [Full Text] [Related]
17. MAOIs - does the evidence warrant their resurrection?
Menkes D; Bosanac P; Castle D
Australas Psychiatry; 2016 Aug; 24(4):371-3. PubMed ID: 26917855
[TBL] [Abstract][Full Text] [Related]
18. Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression.
Kavakbasi E; Baune BT
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):585-588. PubMed ID: 34369903
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase inhibitors potentiate the effects of deep brain stimulation.
Hamani C; Giacobbe P; Diwan M; Balbino ES; Tong J; Bridgman A; Lipsman N; Lozano AM; Kennedy SH; Nobrega JN
Am J Psychiatry; 2012 Dec; 169(12):1320-1. PubMed ID: 23212066
[No Abstract] [Full Text] [Related]
20. Tranylcypromine Plus Amitriptyline for Electroconvulsive Therapy-Resistant Depression: A Long-Term Study.
Ferreira-Garcia R; da Rocha Freire RC; Appolinário JC; Levitan MN; Halkjær-Lassen RD; Bueno JR; Nardi AE
J Clin Psychopharmacol; 2018 Oct; 38(5):502-504. PubMed ID: 30106881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
